Financial Summary (All financials)
In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
Revenues | 59.0 | 7.0 | -9.0 | 6.0 | -2.2 | 4.9 | 0.0 | 27.3 |
Revenue growth | 742.9% | -177.8% | -250.0% | -372.7% | -144.9% | | -100.0% | -11.2% |
Cost of goods sold | 6,166.0 | 7,470.0 | -6,513.0 | 5,526.0 | -4,828.4 | 4,224.2 | 3,540.1 | 4,127.9 |
Gross profit | -6,107.0 | -7,463.0 | 6,504.0 | -5,520.0 | 4,826.2 | -4,219.3 | -3,540.1 | -4,100.6 |
Gross margin | -10350.8% | -106614.3% | -72266.7% | -92000.0% | -219372.7% | -86108.2% | | -15020.5% |
Selling, general and administrative | 1,855.0 | 1,360.0 | 1,367.0 | 1,070.0 | 1,001.5 | 862.3 | 715.6 | 668.3 |
General and administrative | 773.0 | 73.0 | 92.0 | | | | | |
EBITA | 1,611.0 | 1,527.0 | 1,383.0 | -6,865.0 | 6,539.9 | 805.0 | 684.7 | -4,936.8 |
EBITA margin | 2730.5% | 21814.3% | -15366.7% | -114416.7% | -297268.2% | 16428.6% | | -18083.5% |
Amortization of intangibles | 49.0 | 64.0 | 69.0 | 43.0 | 46.4 | 59.0 | 41.9 | 33.4 |
EBIT | 1,562.0 | 1,463.0 | 1,314.0 | -6,908.0 | 6,493.5 | 746.0 | 642.8 | -4,970.2 |
EBIT margin | 2647.5% | 20900.0% | -14600.0% | -115133.3% | -295159.1% | 15224.5% | | -18205.9% |
Pre-tax income | 321.0 | 1,080.0 | 855.0 | 842.0 | 651.1 | 733.3 | 642.8 | 851.4 |
Income taxes | 184.0 | 258.0 | 196.0 | 157.0 | 129.2 | 170.4 | 167.3 | 270.7 |
Tax rate | 57.3% | 23.9% | 22.9% | 18.6% | 19.8% | 23.2% | 26.0% | 31.8% |
Earnings from continuing ops | 70.0 | 785.0 | 634.0 | 685.0 | 521.9 | 562.9 | 475.5 | 580.7 |
Earnings from discontinued ops | 431.0 | 26.0 | 65.0 | 66.0 | | | | |
Net income | 501.0 | 811.0 | 699.0 | 751.0 | 521.9 | 562.9 | 475.5 | 580.7 |
Net margin | 849.2% | 11585.7% | -7766.7% | 12516.7% | -23722.7% | 11487.8% | | 2127.1% |
|
Diluted EPS | $0.36 | $3.83 | $2.60 | $2.76 | $2.09 | $2.27 | $2.11 | $2.54 |
Shares outstanding (diluted) | 193.0 | 205.0 | 244.0 | 248.0 | 249.2 | 247.5 | 225.0 | 228.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|